Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 233, Issue 1-2, Pages 221-227Publisher
ELSEVIER
DOI: 10.1016/j.jneuroim.2010.12.001
Keywords
Parkinson's disease; alpha-synuclein; amyloid toxicity; autoantibodies; T-cells; B-cells
Categories
Ask authors/readers for more resources
The aim was to ascertain any possible linkage between humoral immune responses to principal biomarkers (alpha-synuclein monomers, its toxic oligomers or fibrils, dopamine and S100B) and cellular immunity in Parkinson's disease development. There were elevated autoantibody titers to alpha-synuclein monomers, oligomers plus fibrils in 72%, 56%, and 17% of Parkinsonian patients respectively with a 5-year disease duration. Additionally, there were increased titers to dopamine and S100B (96% and 89%) in the 5-year patient group. All of these values subsided in 10-year sufferers. Furthermore, CD3+, CD4+, CD8+ T-lymphocyte and B-lymphocyte subsets declined in the patient cohort during Parkinsonism indicating disease associated reductions in these lymphocyte subsets. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available